The digital pathology software developer is raising funding that would help it to increase its head count and support its Aiosyn Mitosis Breast application.

as sales of its multiple sclerosis drug fell short of expectations. Cambridge, Mass.-based Biogen had net income of $266.8 million, or $1.83 a share, for the quarter, up from $249.7 million ...

The drug is currently in Phase 3 trials for two types of lupus with initial data readouts expected between 2026 and 2027. Royalty Pharma is an investor in biopharmaceutical royalties and a funder ...

Being mid-period on Valentine’s Day is far from ideal, especially as many women say they neither feel sexy nor enjoy period ...

Weight-loss drugs like Ozempic may decrease your risk of developing 42 health conditions, but increase your chance of experiencing 19 others, according to one of the most comprehensive studies-of ...

I’d had quite a few cocktails, so I was quite drunk, and I honestly can’t remember what my reaction to his penis was. But as ...

Google has been slowly rolling out a redesign of Gemini overlay on Android and more beta users are now seeing it as of Monday morning. The Gemini overlay that opens when you say “Hey Google ...

Last October, Google greatly simplified the Gemini app on mobile. With the overlay redesign on Android, the Gemini homepage continues to get simpler. Original vs. October 2024 design The latest ...

Microsoft is rolling out its new in-game browser overlay on Windows 11 this week, after months of beta testing. The Microsoft Edge Game Assist feature is a widget that appears in the Game Bar in ...

Blockbuster obesity drugs such as Ozempic have been celebrated for their ability to promote weight loss and treat a surprising range of other conditions, from heart problems to Parkinson’s disease.

biotech firm said colorectal cancer patients participating in the DeFianCe phase 2 clinical trial treated with its sirexatamab product candidate plus bevacizumab, a drug sold under the brand ...